Irvine Scientific Introduces Chemically-Defined Natural Killer Cell Expansion Medium for Immunotherapy & Translational Research Applications

Jul 17, 2018 | Posted in Cell Therapy The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells SANTA ANA, California – July 17, 2018: Irvine Scientific, an industry leader in the development and manufacture of cell culture media, today announced the introduction of PRIME-XV® NK Cell CDM— the first commercially available chemically-defined (CDM), animal... Read more

Axol Bioscience Launch Human iPSC-derived Atrial Cardiomyocytes

Cambridge, UK – (17th July 2018) – Axol Bioscience, the human cell culture specialist, provide highly validated primary cells and iPSC-derived cells together with optimised media and growth supplements, launch their Human iPSC-derived Atrial Cardiomyocytes for the discovery and development of novel treatments and advancing our understanding of cardiovascular disease. Generated from the same donor... Read more

NanoView Biosciences Appoints Jerry Williamson as Chief Executive Officer

Company prepares for commercial launch of its innovative products for detection and characterization of Exosomes Boston, MA- NanoView Biosciences, (“NanoView” or the “Company”), an emerging leader in commercializing high value exosome-associated products, today announced that Jerry Williamson has been named as the Company’s new Chief Executive Officer effective July 1, 2018, and continues as a... Read more

Magnetic 3D Cell Culture Provides Promising Solution for Long Standing Issues with Saliva Based Stimulation Therapies for Radiotherapy-induced Xerostomia

Magnetic 3D Cell Culture methods from Greiner Bio-One have now been validated for the creation of innervated secretory epithelial organoids that can provide a promising solution for ineffective saliva-based stimulation therapies for radiotherapy-induced xerostomia. Current saliva-based stimulation therapies are therapeutically limited by the presence of damaged secretory epithelia and nerves in the salivary gland. A... Read more

Bio-Techne Scales Antibody Validation Initiative Using CRISPR Gene Editing Technology Across a Broad Spectrum of Targets

 Download as PDF JULY 10, 2018 Knockout Validation of Antibodies Confirms Specificity and Ensures Reproducible Results MINNEAPOLIS, July 10, 2018 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of antibody-based reagents for life science and clinical research, has been validating an extensive and growing number of antibodies using... Read more

MilliporeSigma to Expand Operations in Gillingham, UK

Jul 02, 2018 Company to expand distribution centre for Life Science products to support future business growth MilliporeSigma, a leading science and technology company, today announced plans to expand its Gillingham, UK distribution centre. The €9 million investment will boost distribution capabilities for the business. Anticipated to open in early 2019, the new facility will... Read more

David King Joins Fluidigm as Vice President, Research and Development, Genomics

SOUTH SAN FRANCISCO, Calif., June 26, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of David King as Vice President, Research and Development, Genomics. As a member of the executive leadership team reporting to President and CEO Chris Linthwaite, King will drive R&D strategy and execution for all genomics products and systems across the company. “Fluidigm is a leader... Read more

10x Genomics Extends their Application Portfolio with the Launch of Single Cell Mouse Immune Profiling Solution

–New solution characterizes single cell gene expression and paired receptor sequences of T- and B-cells in mouse models of disease– PLEASANTON, CA.—June 20, 2018—10x Genomics, a company focused on accelerating discovery, today announced the launch of the Single Cell Mouse Immune Profiling Solution. For the first time, researchers will have the ability to simultaneously and... Read more

FDA approves latest generation somatic cell counting tests for raw milk

20. Jun, 2018 Three FOSS instruments have been approved for official use by NCIMS/FDA in the USA:   • Fossomatic 7 for testing total somatic cell count in raw milk   • Fossomatic 7 DC for testing of total somatic cell count in raw milk   • BacSomatic for testing both total somatic cell count and bacteria count in raw milk... Read more

Lonza to Host New Webinar: “Fast-Track Development of an In Vitro 3D Lung-Immune Cell Model for Enhanced Disease Modeling”

Cologne (DE) / Walkersville, MD (USA), 15 June 2018 – On 25 June 2018, Lonza, in collaboration with Kirkstall Ltd., a biotechnology company based in Rotherham (UK), is hosting a free 60-minute webinar on the development of more physiologically relevant 3D lung-immune cell models for enhanced disease modeling. Conventional in vitro lung models often involve... Read more